A 42-year-old man with acute leukemia undergoing chemotherapy develops fever (38.8°C), chills, and hypotension. Blood cultures are pending. Physical examination reveals no obvious source of infection. He is on broad-spectrum antibiotics for 5 days without improvement. What is the most appropriate next step in management?

Explanation

## Clinical Scenario: Fever in Neutropenic Host This patient has: - Acute leukemia with chemotherapy-induced neutropenia - Fever (≥38.8°C) with hemodynamic instability (hypotension) - No source identified despite 5 days of broad-spectrum antibiotics - Pending blood cultures This clinical picture is highly suspicious for **invasive fungal infection** (candidemia or other fungemia) in a neutropenic host. **Key Point:** Neutropenic fever that persists despite 4–7 days of appropriate antibiotics warrants empiric antifungal therapy WITHOUT waiting for culture results. [cite:Harrison 21e Ch 211] ## Empiric Antifungal Therapy in Neutropenic Fever ```mermaid flowchart TD A[Neutropenic patient with fever]:::outcome --> B{Duration of fever on antibiotics?}:::decision B -->|< 4 days| C[Continue antibiotics<br/>Reassess source]:::action B -->|4-7 days, no source| D[Start empiric antifungal]:::action D --> E{First-line agent?}:::decision E -->|Non-severe| F[Caspofungin IV]:::action E -->|Severe/unstable| G[Liposomal amphotericin B]:::action F --> H[Blood cultures + imaging<br/>as clinically indicated]:::action G --> H H --> I[De-escalate if culture negative<br/>at 2 weeks]:::outcome ``` ## Antifungal Agents for Invasive Candidiasis in Neutropenia | Agent | Dose | Spectrum | First-Line? | Notes | | --- | --- | --- | --- | --- | | **Caspofungin** | 70 mg load, then 50 mg daily | *Candida* spp., *Aspergillus* | Yes | Echinocandin; excellent lung penetration | | Liposomal amphotericin B | 3–5 mg/kg daily | Broad (fungi + some bacteria) | If severe/unstable | Nephrotoxicity risk; monitor creatinine | | Fluconazole | 400–800 mg daily | *Candida* (not *C. glabrata*, *C. auris*) | No | Resistance emerging; not empiric | | Voriconazole | 6 mg/kg BD load, then 4 mg/kg BD | *Candida*, *Aspergillus* | No | Hepatotoxicity; drug interactions | **High-Yield:** In hemodynamically unstable neutropenic patients with fever unresponsive to antibiotics, **empiric caspofungin is started immediately** — do not wait for blood culture results. Mortality increases with each day of delayed antifungal therapy. [cite:Infectious Diseases Society of America (IDSA) Candidiasis Guidelines 2016] **Clinical Pearl:** The 4–7 day threshold for empiric antifungal therapy in neutropenic fever is a landmark guideline. Waiting for culture results in a septic, hemodynamically unstable patient risks death from disseminated candidiasis. ## Why Immediate Therapy is Critical **Warning:** Delaying antifungal therapy in invasive candidiasis increases mortality by ~5–10% per day. Blood cultures have low sensitivity (50–60%) for candidemia, so culture-negative results do NOT exclude invasive candidiasis.